Is there any rule for antiviral therapy in HBV-related compensated cirrhosis patients with serum HBV DNA undetectable or at low levels and normal ALT?

被引：0

作者：

Yan, Taotao ^{[1
]}

Sha, Xiaoying ^{[3
]}

Wang, Jing ^{[1
]}

Jin, Li ^{[1
]}

Zhang, Yu ^{[2
]}

Yi, Ruitian ^{[1
]}

Cao, Furong ^{[1
]}

Yang, Yuan ^{[2
]}

Liu, Jinfeng ^{[2
]}

He, Yingli ^{[2
]}

Chen, Tianyan ^{[2
]}

Zhao, Yingren ^{[2
]}

机构：

[1] Xi An Jiao Tong Univ, Xian 710049, Peoples R China

[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, Xian 710049, Peoples R China

[3] Eighth Hosp Xian, Dept Infect Dis, Xian, Peoples R China

来源：

HEPATOLOGY | 2015年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1541

引用

页码：961A / 962A

页数：3

共 50 条

[1] Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious
Giri, Suprabhat
Darak, Harish
Kasturi, Sunil
DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (10) : 4962 - 4964
[2] Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious
Suprabhat Giri
Harish Darak
Sunil Kasturi
Digestive Diseases and Sciences, 2022, 67 : 4962 - 4964
[3] DEVELOPMENT OF PREDICTION MODELS FOR HBV-RELATED LIVER CIRRHOSIS BY INTEGARTING HBV GENOTYPE AND SERUM LEVELS OF HBV DNA AND HBSAG
Lee, M. -H.
Yang, H. -I.
Liu, J.
Batrla-Utermann, R.
Jen, C. -L.
Iloeje, U. H.
Su, J.
Lu, S. -N.
You, S. -L.
Wang, L. -Y.
Chen, C. -J.
JOURNAL OF HEPATOLOGY, 2012, 56 : S186 - S187
[4] Baseline Platelet Is an Independent Predictor for Liver- Related Events after Antiviral Therapy for Compensated HBV-Related Cirrhosis
Wu, Xiaoning
Zhou, Jialing
Wang, Lin
Sun, Yameng
Ou, Xiaojuan
You, Hong
Jia, Jidong
Chen, Guofeng
Xie, Wen
Ding, Huiguo
Ma, Hui
Ma, Anlin
Xu, Youqing
HEPATOLOGY, 2018, 68 : 1238A - 1239A
[5] Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma
Li, Chuan
Li, Zhi-Cheng
Ma, Liang
Li, Le-Qun
Zhong, Jian-Hong
Xiang, Bang-De
Gong, Wen-Feng
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (08) : 749 - 756
[6] The Progress of Antiviral Therapy in Patients with HBV-Related Liver Failure
Zhou, Qiaoling
Tang, Hong
HEPATO-GASTROENTEROLOGY, 2013, 60 (128) : 1877 - 1880
[7] Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy
Nam, Joon Yeul
Sinn, Dong Hyun
Bae, Junho
Jang, Eun Sun
Kim, Jin-Wook
Jeong, Sook-Hyang
JHEP REPORTS, 2020, 2 (06)
[8] Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM
Wang, Bingqiong
Zhou, Jialing
Wu, Xiaoning
Sun, Yameng
Li, Lei
Li, Ping
Li, Minghui
Jiang, Wei
Xu, Mingyi
Feng, Bo
Xu, Xiaoyuan
Cheng, Jilin
Xie, Wen
Han, Tao
Wang, Xiaozhong
Li, Hai
Piao, Hongxin
Wu, Shanshan
Shi, Yiwen
Chen, Shuyan
Kong, Yuanyuan
Ma, Hong
Ou, Xiaojuan
Jia, Jidong
You, Hong
LIVER INTERNATIONAL, 2021, 41 (02) : 369 - 377
[9] Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
Huang, Daniel Q. Q.
Tamaki, Nobuharu
Lee, Hyung Woong
Park, Soo Young
Lee, Yu Rim
Lee, Hye Won
Lim, Seng Gee
Lim, Tae Seop
Kurosaki, Masayuki
Marusawa, Hiroyuki
Mashiba, Toshie
Kondo, Masahiko
Uchida, Yasushi
Kobashi, Haruhiko
Furuta, Koichiro
Izumi, Namiki
Kim, Beom Kyung
Sinn, Dong Hyun
HEPATOLOGY, 2023, 77 (05) : 1746 - 1756
[10] ALBUMIN AND PLATELET AFTER SIX MONTHS OF ANTIVIRAL THERAPY ARE INDEPENDENT SERUM MARKERS TO PREDICT LIVER RELATED EVENTS IN HBV-RELATED COMPENSATED LIVER CIRRHOSIS
Wu, Xiaoning
Zhou, Jialing
Meng, Tongtong
Sun, Yameng
Wang, Bingqiong
Piao, Hongxin
Ding, Huiguo
Xu, Xiaoyuan
Jiang, Wei
Chen, Yongpeng
Xie, Wen
Ma, Anlin
Cheng, Jun, Sr.
Cheng, Jilin
Zhang, Mingxiang
Guan, Qiushuang
Chen, Shuyan
Shi, Yiwen
Duan, Weijia
Kong, Yuanyuan
Ou, Xiaojuan
You, Hong
Jia, Jidong
HEPATOLOGY, 2019, 70 : 424A - 424A

← 1 2 3 4 5 →